Bridging the antiviral gap: A BAC-based non-infectious SARS-CoV-2 replicon reveals potent antisense gapmers

Molecular Therapy: Nucleic Acids · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles